Literature DB >> 6983323

Detection of chloramphenicol acetyltransferase (CAT) activity in a strain of Haemophilus ducreyi.

M J Sanson-Le Pors, I M Casin, M Ortenberg, Y Perol.   

Abstract

The minimal inhibitory concentration (MIC) of chloramphenicol for a clinical isolate of Haemophilus ducreyi, strain CEB-10, was 16 micrograms/ml. This strain was also resistant to tetracycline (MIC = 64 micrograms/ml) and ampicillin. The presence of a chloramphenicol acetyltransferase (CAT) activity was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983323

Source DB:  PubMed          Journal:  Ann Microbiol (Paris)        ISSN: 0300-5410


  6 in total

Review 1.  Antimicrobial susceptibility of Haemophilus ducreyi.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

2.  Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi.

Authors:  M J Sanson-le Pors; I M Casin; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

3.  In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.

Authors:  M J Sanson-Le Pors; I M Casin; M C Thebault; G Arlet; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

4.  Plasmid-mediated tetracycline resistance in Haemophilus ducreyi.

Authors:  W L Albritton; I W Maclean; L A Slaney; A R Ronald; H G Deneer
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

5.  Molecular characterization of chloramphenicol-resistant Haemophilus parainfluenzae and Haemophilus ducreyi.

Authors:  M C Roberts; L A Actis; J H Crosa
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

Review 6.  Chancroid and Haemophilus ducreyi.

Authors:  S A Morse
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.